Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XFOR

X4 Pharmaceuticals Inc

May 13 • 04:00PM ET

4.23

-0.11 -2.53 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: COGT MREO SRRK ABEO NRIX

| Held by: VTI VXF AVSC PRFZ BTEC URTY ITWO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.54	Insider Own	9.56%	Shs Outstand	94.32M	Perf Week	-3.42%
Market Cap	398.97M	Forward P/E	-	EPS next Y	-0.78	Insider Trans	-0.19%	Shs Float	85.31M	Perf Month	0.71%
Enterprise Value	242.50M	PEG	-	EPS next Q	-0.18	Inst Own	78.29%	Short Float	3.65%	Perf Quarter	23.32%
Income	-99.72M	P/S	44.28	EPS this Y	60.07%	Inst Trans	51.59%	Short Ratio	6.57	Perf Half Y	16.53%
Sales	9.01M	P/B	2.37	EPS next Y	-4.46%	ROA	-49.82%	Short Interest	3.12M	Perf YTD	5.75%
Book/sh	1.79	P/C	1.71	EPS next 5Y	31.35%	ROE	-104.21%	52W High	4.83 -12.42%	Perf Year	27.79%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	65.48% 54.19%	ROIC	-40.71%	52W Low	1.35 213.33%	Perf 3Y	-90.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 63.56%	Gross Margin	79.04%	Volatility	5.33% 5.67%	Perf 5Y	-98.11%
Dividend TTM	-	EV/Sales	26.91	EPS Y/Y TTM	-300.04%	Oper. Margin	-1084.38%	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.98	Sales Y/Y TTM	-71.26%	Profit Margin	-1106.30%	RSI (14)	50.58	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.18	EPS Q/Q	-490.02%	SMA20	-0.32%	Beta	0.33	Target Price	11.67
Payout	-	Debt/Eq	0.46	Sales Q/Q	-90.60%	SMA50	2.40%	Rel Volume	0.52	Prev Close	4.34
Employees	45	LT Debt/Eq	0.45	Earnings	May 06 BMO	SMA200	17.38%	Avg Volume	474.50K	Price	4.23
IPO	Nov 16, 2017	Option/Short	No / Yes	EPS/Sales Surpr.	20.00% -22.84%	Trades		Volume	245,223	Change	-2.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)